One Biosciences, an Institut Curie-backed startup building AI-driven single-cell profiling tools for tumor ecosystems, selected Albany, New York as its first U.S. location. The company plans a high-complexity lab and computational analytics operation supported by Empire State Development, including up to $525,000 in performance-based Excelsior Jobs Program tax credits in exchange for job and investment commitments. One Biosciences said its Albany hub will serve as the U.S. node for collaborations with pharma, biotech, and academic partners, focusing on single-cell characterization approaches intended to improve how tumor ecosystems are mapped. The move reflects ongoing geographic expansion of single-cell-enabled oncology tooling and the emphasis on building domestic infrastructure for advanced analytics workloads.